Abstract

Research on the use of plants for the production of vaccine antigens has increased greatly since the seminal studies published in the early 1990s. The initial strategy focused on oral delivery of minimally processed edible material from stably transgenic plants. Although substantial regulatory concerns exist regarding the use of food crops for vaccine production, the potential for vaccines expressed in seeds of corn and rice is especially promising. However, more recent development of robust transient expression systems greatly improved the potential to use plants for expression purification of recombinant antigens for more typical injectable delivery. Significant industrial development of methods for production of plant-made vaccines rapidly and at large-scale demonstrates the exciting capabilities of the technology. Notably, transient expression in leaves of Nicotiana benthamiana shows great potential for the production of several vaccines for human viral pathogens. Future work will address issues of processing plant material for optimal oral or parenteral delivery.

Original languageEnglish (US)
Title of host publicationMolecular Pharming
Subtitle of host publicationApplications, Challenges and Emerging Areas
PublisherWiley-Blackwell
Pages231-273
Number of pages43
ISBN (Electronic)9781118801512
ISBN (Print)9781118801284
DOIs
StatePublished - Sep 12 2018

Fingerprint

Vaccines
Viral Vaccines
Antigens
Genetically Modified Plants
Zea mays
Tobacco
Pathogens
Seeds
Crops
Purification
Seed
Technology
Food
Injections
Research
Processing

Keywords

  • Chimeric plant virus
  • Chimeric VLPs
  • Immune complex
  • Plant-made biologic
  • Plant-made pharmaceutical
  • Plant-made vaccine
  • Transient expression
  • Vaccine
  • Virus-like particle (VLP)

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Chen, Q., Dent, M., & Mason, H. (2018). Molecular Pharming: Plant-Made Vaccines. In Molecular Pharming: Applications, Challenges and Emerging Areas (pp. 231-273). Wiley-Blackwell. https://doi.org/10.1002/9781118801512.ch10

Molecular Pharming : Plant-Made Vaccines. / Chen, Qiang; Dent, Matthew; Mason, Hugh.

Molecular Pharming: Applications, Challenges and Emerging Areas. Wiley-Blackwell, 2018. p. 231-273.

Research output: Chapter in Book/Report/Conference proceedingChapter

Chen, Q, Dent, M & Mason, H 2018, Molecular Pharming: Plant-Made Vaccines. in Molecular Pharming: Applications, Challenges and Emerging Areas. Wiley-Blackwell, pp. 231-273. https://doi.org/10.1002/9781118801512.ch10
Chen Q, Dent M, Mason H. Molecular Pharming: Plant-Made Vaccines. In Molecular Pharming: Applications, Challenges and Emerging Areas. Wiley-Blackwell. 2018. p. 231-273 https://doi.org/10.1002/9781118801512.ch10
Chen, Qiang ; Dent, Matthew ; Mason, Hugh. / Molecular Pharming : Plant-Made Vaccines. Molecular Pharming: Applications, Challenges and Emerging Areas. Wiley-Blackwell, 2018. pp. 231-273
@inbook{b04d70165ad64c58b21057f02a545ec7,
title = "Molecular Pharming: Plant-Made Vaccines",
abstract = "Research on the use of plants for the production of vaccine antigens has increased greatly since the seminal studies published in the early 1990s. The initial strategy focused on oral delivery of minimally processed edible material from stably transgenic plants. Although substantial regulatory concerns exist regarding the use of food crops for vaccine production, the potential for vaccines expressed in seeds of corn and rice is especially promising. However, more recent development of robust transient expression systems greatly improved the potential to use plants for expression purification of recombinant antigens for more typical injectable delivery. Significant industrial development of methods for production of plant-made vaccines rapidly and at large-scale demonstrates the exciting capabilities of the technology. Notably, transient expression in leaves of Nicotiana benthamiana shows great potential for the production of several vaccines for human viral pathogens. Future work will address issues of processing plant material for optimal oral or parenteral delivery.",
keywords = "Chimeric plant virus, Chimeric VLPs, Immune complex, Plant-made biologic, Plant-made pharmaceutical, Plant-made vaccine, Transient expression, Vaccine, Virus-like particle (VLP)",
author = "Qiang Chen and Matthew Dent and Hugh Mason",
year = "2018",
month = "9",
day = "12",
doi = "10.1002/9781118801512.ch10",
language = "English (US)",
isbn = "9781118801284",
pages = "231--273",
booktitle = "Molecular Pharming",
publisher = "Wiley-Blackwell",
address = "United States",

}

TY - CHAP

T1 - Molecular Pharming

T2 - Plant-Made Vaccines

AU - Chen, Qiang

AU - Dent, Matthew

AU - Mason, Hugh

PY - 2018/9/12

Y1 - 2018/9/12

N2 - Research on the use of plants for the production of vaccine antigens has increased greatly since the seminal studies published in the early 1990s. The initial strategy focused on oral delivery of minimally processed edible material from stably transgenic plants. Although substantial regulatory concerns exist regarding the use of food crops for vaccine production, the potential for vaccines expressed in seeds of corn and rice is especially promising. However, more recent development of robust transient expression systems greatly improved the potential to use plants for expression purification of recombinant antigens for more typical injectable delivery. Significant industrial development of methods for production of plant-made vaccines rapidly and at large-scale demonstrates the exciting capabilities of the technology. Notably, transient expression in leaves of Nicotiana benthamiana shows great potential for the production of several vaccines for human viral pathogens. Future work will address issues of processing plant material for optimal oral or parenteral delivery.

AB - Research on the use of plants for the production of vaccine antigens has increased greatly since the seminal studies published in the early 1990s. The initial strategy focused on oral delivery of minimally processed edible material from stably transgenic plants. Although substantial regulatory concerns exist regarding the use of food crops for vaccine production, the potential for vaccines expressed in seeds of corn and rice is especially promising. However, more recent development of robust transient expression systems greatly improved the potential to use plants for expression purification of recombinant antigens for more typical injectable delivery. Significant industrial development of methods for production of plant-made vaccines rapidly and at large-scale demonstrates the exciting capabilities of the technology. Notably, transient expression in leaves of Nicotiana benthamiana shows great potential for the production of several vaccines for human viral pathogens. Future work will address issues of processing plant material for optimal oral or parenteral delivery.

KW - Chimeric plant virus

KW - Chimeric VLPs

KW - Immune complex

KW - Plant-made biologic

KW - Plant-made pharmaceutical

KW - Plant-made vaccine

KW - Transient expression

KW - Vaccine

KW - Virus-like particle (VLP)

UR - http://www.scopus.com/inward/record.url?scp=85050046743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050046743&partnerID=8YFLogxK

U2 - 10.1002/9781118801512.ch10

DO - 10.1002/9781118801512.ch10

M3 - Chapter

SN - 9781118801284

SP - 231

EP - 273

BT - Molecular Pharming

PB - Wiley-Blackwell

ER -